REBROVICK LINDA sold $420K of HSTM
REBROVICK LINDA sold 12,000 shares of HEALTHSTREAM INC (HSTM) at $35.00 ($0.42M total) on 2026-10-23 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides fresh, primary‑source information about insider activity, which may influence short‑term sentiment.
Market read
Insider sales are monitored by traders; while the amount is modest, the director's involvement could affect perception.
What to watch
No accompanying corporate news or earnings release that would amplify the effect.
Background
Healthstream Inc. (NASDAQ:HSTM) filed a Form 4 reporting a director's sale of shares under a pre‑arranged 10b5‑1 plan.
Ticker impact
Director Linda Rebrovick sold 12,000 shares for $420,000 via a 10b5-1 plan, reducing her stake to 39,329 shares.
likely downward pressure as the market prices in the insider sell
Form 4 filing is a primary source; the transaction size is modest but notable for a director, suggesting potential short-term sell pressure.
Market effects
Minimal impact on the broader health‑tech sector; only a single insider transaction.
None
None
Counterpoint
The sale could be routine liquidity planning under a 10b5‑1 plan, not a negative signal.
Key entities
- companyHealthstream Inc.
US‑listed health‑technology firm
- personLinda Rebrovick
Director of Healthstream Inc.
